The Effect of Adding Pain Relievers to Local Anesthesia Before Preforming Drainage in Peritonsillar Abscess

The Efficiency of DYPIRON and TRAMADOL in Addition to Local Anesthesia Prior to Incision and Drainage Procedure in Peritonsillar Abscess

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01227200

Acronym

pta

Enrollment

Registered

2010-10-25

Start date

2011-11-30

Completion date

2011-12-31

Last updated

2010-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritonsillar Abscess

Brief summary

The purpose of this study is to find if adding oral pain relievers as DYPIRON and TRAMADOL in addition to the local anesthesia injection, can help reducing the pain intensity in patients who diagnosed as Suffering from peritonsillar abscess (PTA)and treated by incision and drainage .

Detailed description

Control group: the patient will get local anesthesia injection with Lidocain. After 5 minutes- the DR will preform the incision and drainage of the abscess. Then the patient will be asked by the vas score, the the pain intensity that he feels. Intervention group:the patient will get dypiron 4 ml and tramadol 50 mg. after 40 minutes,the patient will get local anesthesia injection with Lidocain. After 5 minutes- the DR will preform the incision and drainage of the abscess.then the patient will be asked by the vas score, the the pain intensity that he feels.

Interventions

DRUGdypiron, tramadol

dypiron 4 ML, tramadol 50 mg flashtab

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

patients with PTA in ages 18-65, who agreed to join the research -

Exclusion criteria

cave to dypiron and/or tramadol, pregnant women, mental illness,soldiers. \-

Design outcomes

Primary

Measure	Time frame
the vas scale	40 min after giving the oral drugs

Countries

Israel

Contacts

Primary Contactshani fisher, RN BA

SUNSHAN2@GMAIL.COM046494311

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026